MENU
MESO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Mesoblast (MESO) Ownership - Who owns Mesoblast?

Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
55 Collins Street
Phone
+61 396396036
Employees
81
Web
https://www.mesoblast.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.86B
P/E Ratio
N/A
Total Cash
129.58M
Projected Growth
N/A
Total Debt
135.14M
Revenue
65.38M
Risk (Beta)
1.65
Dividend Yield
N/A
Total Cash/Share
1.00
Total Debt/Equity
N/A
Revenue/Share
0.51 USD as % of share price
View a ticker or compare two or three
MESO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the development and commercialization of biological products

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
55 Collins Street
Phone
+61 396396036
Employees
81
Web
https://www.mesoblast.com